Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results
Date:11/6/2013

ytren's contracture patients with a palpable cord in the U.S. Ferring International Center S.A. markets Testim in certain countries of the EU and Paladin Labs Inc. markets Testim in Canada.  Swedish Orphan Biovitrium AB has marketing rights for XIAPEX (the EU tradename for CCH) in 71 Eurasian and African countries.  Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in Japan and Actelion Pharmaceuticals Ltd has development and commercial rights for XIAFLEX in Canada, Australia, Brazil and Mexico.  Auxilium also markets TESTOPEL, a long-acting implantable testosterone replacement therapy, Edex, the leading branded non-oral drug for erectile dysfunction, Striant®, a buccal system for testosterone delivery, Osbon ErecAid®, the leading device for aiding erectile dysfunction, and also has a non-promoted respiratory franchise, including Theo-24® and Semprex®-D, along with three other non-promoted products, in the U.S.  Auxilium has exclusive marketing rights in the U.S. and Canada for STENDRA, an oral erectile dysfunction therapy.  Auxilium has three projects in clinical development.  XIAFLEX is currently under regulatory review by the U.S. FDA for the treatment of Peyronie's disease.  CCH is in Phase 2 of development for the treatment of Frozen Shoulder syndrome (adhesive capsulitis) and Phase 2 of development for the treatment of cellulite (edematous fibrosclerotic panniculopathy).  Auxilium also has rights to pursue additional indications for XIAFLEX. For additional information, visit http://www.auxilium.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995, which discuss matters that are not facts, and may include words to indicate their uncertain nature such as "believe," "expect
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... -- Based on its recent analysis of the breast imaging solutions ... North American Frost & Sullivan Award for Technology Innovation Leadership. ... solutions for the early detection of breast cancer. Over the ... solutions and has expanded its global reach to cover ... , Asia and Australia ...
(Date:8/26/2014)... 26, 2014 Novira Therapeutics, Inc., a privately ... of chronic hepatitis B virus (HBV) infection, today announced ... appointed the Chair of its Scientific Advisory Board (SAB). ... Senior Advisor to the Company.  "We ... Chair," said Christian Schade , Chief Executive Officer ...
(Date:8/26/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.22 per share will ... of record as of the close of business on September ... of the Board of Directors and may be adjusted as ...
Breaking Medicine Technology:Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... Calif., Dec. 6 DURECT Corporation,(Nasdaq: ... Phase III trial for Remoxy,had successfully met ... by the U.S. Food and Drug Administration ... an investigational drug based on,DURECT,s patented ORADUR(TM) ...
... Colo., Dec. 5 Replidyne, Inc.,(Nasdaq: RDYN ) ... Collins will participate on the New and Powerful Anti-infectives,panel ... panel,discussion will take place at 11:00 am ET on ... New York City., A live audio webcast of ...
Cached Medicine Technology:Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 2Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 3Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 4
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... governance, and compliance software solutions for next-generation social ... Inc. magazine’s Inc. 500|5000, an exclusive ranking of ... consecutive year. AvePoint joins brands such as Alex ... 2014 edition. , This underscores continued growth ...
(Date:8/27/2014)... BambooIndustry.com is one of the most loved online bamboo product ... sale now. Recently, it has announced its new selection of ... BambooIndustry.com strives to offer one-stop shopping solutions for people who ... Now, it is providing big discounts for all the brand ... enjoy a discounted price (up to 30% off) before the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... on August 1, that Organic Raw Carob Powder sold ... recalled due to possible contamination with Salmonella. ... with weakened immune systems. In healthy people it can ...
(Date:8/27/2014)... Crossing, PA (PRWEB) August 27, 2014 Time ... successfully launched its first-ever golf event! , With 80-degree ... for the Time To Play Golf (TTPGolf) Inaugural Outing. Around ... August 4th event, staged at the beautiful Heron Glen Golf ... with a bang and everyone seemed to be having a ...
(Date:8/27/2014)... OR (PRWEB) August 27, 2014 The ... improve quality of life and may eliminate the need ... controversy. During a recent AllMed webinar, Dr. Zanhua Yi, ... issues related to determining medical necessity of erythropoiesis-stimulating agents ... disease (CKD). , The U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3
... The Songs of Love ... uplifting, personalized songs for children and teens struggling with a life-threatening ... professionally produced with lyrics containing the child,s name and references to ... Songs are written and performed in the musical style that the ...
... improved hearing and alleviated other symptoms in patients with ... appear in the July 23 New England Journal ... researchers from Massachusetts General Hospital (MGH) report that bevacizumab ... of NF2 patients, the first reported successful NF2 treatment ...
... The world-wide explosion of overweight people has been called ... recognized. Could it really be an epidemic involving an ... increasing prevalence of overweight conditions in our society, investigators ... as a potential direct contributor to obesity. ...
... WASHINGTON, July 8 The results of a study published ... Journal (BMJ) support the findings of a white paper released ... (SCHS) regarding the potentially lifesaving qualities of cholesterol lowering drugs ... "In patients without established cardiovascular disease but with cardiovascular risk ...
... , TROIS-RIVIERES, Quebec, July 8 The Narconon drug rehab ... involved with drug related charges due to their addiction. ... a drug addiction, and just one day gets caught by ... a representative of Narconon Trois-Rivieres. "This is an all ...
... July 8 On the heels of a new campaign launched ... to unsightly "canckles," Dr. Marc Mittleman, founder and director of ... clubs and their members to focus on a real health issue ... in warm, moist environments like locker rooms, communal showers, pool and ...
Cached Medicine News:Health News:Donate Your Car to the Songs of Love Car Donation Program 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 3Health News:British Medical Journal Report Supports SCHS White Paper on Statins 2Health News:Drug Crimes in Canada Cause Continuing Problems for Small Communities 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 3
30 cm - 11 3/4, packages 5 pcs....
Galt Skull Trephine with adjustable centering point and detachable cross-bar handle, 19.0 mm....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
Medicine Products: